This study shows for the first time that, in patients with CAD, platelet activation begins at night to finish at 8am. To understand the mechanism(s) accounting for the nocturnal rise in 11-d-TxB2 could help determining new strategies to prevent acute coronary syndrome.
Nocturnal rise of urinary thromboxane B-2 in patients with coronary artery disease / F. L., Fimognari; Piccirillo, Gianfranco; J., Lama; DE MARZIO, Paolo; Morelli, Sergio; G., Monteleone; V., Mollace; Violi, Francesco. - In: THROMBOSIS AND HAEMOSTASIS. - ISSN 0340-6245. - 93:(2005), pp. 618-619. [10.1267/thro05030618]
Nocturnal rise of urinary thromboxane B-2 in patients with coronary artery disease
PICCIRILLO, Gianfranco;DE MARZIO, Paolo;MORELLI, Sergio;VIOLI, Francesco
2005
Abstract
This study shows for the first time that, in patients with CAD, platelet activation begins at night to finish at 8am. To understand the mechanism(s) accounting for the nocturnal rise in 11-d-TxB2 could help determining new strategies to prevent acute coronary syndrome.File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
